---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-312941"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2025-12-09T23:59:59+00:00"
generated_at: "2026-05-16T13:54:29.986946+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Teleflex sells Acute Care, Interventional Urology, and OEM businesses for $2.03B; authorizes $1B buyback

## Summary
- Total cash consideration $2.03B: OEM business to Montagu/Kohlberg for $1.5B; Acute Care and Interventional Urology to Intersurgical for $530M.
- Net after-tax proceeds expected ~$1.8B; primarily used for share repurchases and debt reduction.
- Board authorized $1B share repurchase program, funded from transaction proceeds.
- Transactions expected to close in H2 2026, subject to regulatory approvals and customary conditions.
- Teleflex will focus on remaining core businesses: Vascular Access, Interventional, and Surgical, targeting mid-single-digit growth.

## SEC filing metadata
- accession: 0001193125-25-312941
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2025-12-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000119312525312941/0001193125-25-312941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000119312525312941/d30566d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-312941
- JSON: https://secwatch.observer/filing/0001193125-25-312941.json
- Plain text: https://secwatch.observer/filing/0001193125-25-312941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.